Literature DB >> 18998663

Synthesis and structure-activity relationship studies of 2-(N-substituted)-aminobenzimidazoles as potent negative gating modulators ofsmall conductance Ca2+-activated K+ channels.

Ulrik S Sørensen1, Dorte Strøbaek, Palle Christophersen, Charlotte Hougaard, Marianne L Jensen, Elsebet Ø Nielsen, Dan Peters, Lene Teuber.   

Abstract

Small conductance Ca2+-activated K+ channels (SK channels) participate in the control of neuronal excitability, in the shaping of action potential firing patterns, and in the regulation of synaptic transmission.SK channel inhibitors have the potential of becoming new drugs for treatment of various psychiatric and neurological diseases such as depression, cognition impairment, and Parkinson's disease. In the present study we describe the structure-activity relationship (SAR) of a class of 2-(N-substituted)-2-aminobenzimidazoles that constitute a novel class of selective SK channel inhibitors that, in contrast to classical SK inhibitors, do not block the pore of the channel. The pore blocker apamin is not displaced by these compounds in binding studies, and they still inhibit SK channels in which the apamin binding site has been abolished by point mutations. These novel SK inhibitors shift the concentration-response curve for Ca2+ toward higher values and represent the first example of negative gating modulation as a mode-of-action for inhibition of SK channels. The first described compound in this class is NS8593 (14), and the most potent analogue identified in this study is the racemic compound 39 (NS11757), which reversibly inhibits SK3-mediated currents with a K(d) value of 9 nM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18998663     DOI: 10.1021/jm800809f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

Review 1.  Pharmacological gating modulation of small- and intermediate-conductance Ca(2+)-activated K(+) channels (KCa2.x and KCa3.1).

Authors:  Palle Christophersen; Heike Wulff
Journal:  Channels (Austin)       Date:  2015-07-28       Impact factor: 2.581

2.  Natural and synthetic modulators of SK (K(ca)2) potassium channels inhibit magnesium-dependent activity of the kinase-coupled cation channel TRPM7.

Authors:  V Chubanov; M Mederos y Schnitzler; M Meißner; S Schäfer; K Abstiens; T Hofmann; T Gudermann
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  Pharmacological blockade of small conductance Ca2+-activated K+ channels by ICA reduces arrhythmic load in rats with acute myocardial infarction.

Authors:  Laura A Hundahl; Stefan M Sattler; Lasse Skibsbye; Jonas G Diness; Jacob Tfelt-Hansen; Thomas Jespersen
Journal:  Pflugers Arch       Date:  2017-03-11       Impact factor: 3.657

4.  Negative gating modulation by (R)-N-(benzimidazol-2-yl)-1,2,3,4-tetrahydro-1-naphthylamine (NS8593) depends on residues in the inner pore vestibule: pharmacological evidence of deep-pore gating of K(Ca)2 channels.

Authors:  David Paul Jenkins; Dorte Strøbæk; Charlotte Hougaard; Marianne L Jensen; Rene Hummel; Ulrik S Sørensen; Palle Christophersen; Heike Wulff
Journal:  Mol Pharmacol       Date:  2011-03-01       Impact factor: 4.436

5.  A new negative allosteric modulator, AP14145, for the study of small conductance calcium-activated potassium (KCa 2) channels.

Authors:  Rafel Simó-Vicens; Jeppe E Kirchhoff; Bernardo Dolce; Lea Abildgaard; Tobias Speerschneider; Ulrik S Sørensen; Morten Grunnet; Jonas G Diness; Bo H Bentzen
Journal:  Br J Pharmacol       Date:  2017-10-22       Impact factor: 8.739

6.  Allosteric block of KCa2 channels by apamin.

Authors:  Cédric Lamy; Samuel J Goodchild; Kate L Weatherall; David E Jane; Jean-François Liégeois; Vincent Seutin; Neil V Marrion
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

7.  Antidepressant activity of pharmacological and genetic deactivation of the small-conductance calcium-activated potassium channel subtype-3.

Authors:  Mina G Nashed; Shannon Waye; S M Nageeb Hasan; Diana Nguyen; Micaela Wiseman; Jing Zhang; Harry Lau; O Chandani Dinesh; Roger Raymond; Iain R Greig; Francis Rodriguez Bambico; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2022-01-04       Impact factor: 4.530

Review 8.  Trafficking of intermediate (KCa3.1) and small (KCa2.x) conductance, Ca(2+)-activated K(+) channels: a novel target for medicinal chemistry efforts?

Authors:  Corina M Balut; Kirk L Hamilton; Daniel C Devor
Journal:  ChemMedChem       Date:  2012-08-07       Impact factor: 3.466

Review 9.  Potassium Channels: A Potential Therapeutic Target for Parkinson's Disease.

Authors:  Xiaoyan Chen; Bao Xue; Jun Wang; Haixia Liu; Limin Shi; Junxia Xie
Journal:  Neurosci Bull       Date:  2017-09-07       Impact factor: 5.203

Review 10.  Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.

Authors:  Deepanjali Dwivedi; Upinder S Bhalla
Journal:  Front Mol Neurosci       Date:  2021-06-03       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.